Moreover, our analysis of sEVs isolatedfrom plasma of an NSCLC patient and where two targets of relevancefor treatment were explored, PD-L1 and CD73 respectively, illustratesthe future prospect of the microchip in a clinical setting of oncology. The gene discussed is CD274; the disease is non-small cell lung carcinoma.